About Experimental Biology and Medicine

Scope

The Bioimaging category invites original manuscripts and review papers in all fields of biomedical imaging including the development and applications of novel technologies for molecular, metabolic, ultrastructural, anatomical, and functional imaging of human and animals. Areas of interest encompass from whole organism, to tissues and cells, particularly including research in the field of morphological and functional mapping of the brain of human and animals with X-ray computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), transcranial magnetic stimulation (TMS), magnetoencephalography (MEG), electroencephalogram mapping, ultrasound imaging, photoacoustic imaging, optical coherence tomography, multiphoton microscopy, and other emerging technologies. Papers that focus on the investigations and studies in the following subjects and fields are welcome: (1) Investigation of the morphological and functional architecture of single organs, tissues, and cells that provide novel and interesting results on the relation between structure, and function either in physiological or pathological conditions; (2) novel non-invasive methodologies for the investigation of single organs, tissues, and cells with potential applications in the diagnostic or therapeutic domain; (3) research that combines multiple investigative approaches, such as genetics and imaging, or imaging with pharmacological probes; (4) studies on the in vivo imaging of the molecular mechanisms that underlie cognition and mental activity in healthy conditions as well as in the presence of neurological and psychiatric disorders and of the effects of pharmacological and non-pharmacological treatments. Manuscripts will be reviewed on the basis of scientific merit and respect of internationally accepted ethical standards for animal and human research. Submission of purely clinical studies is discouraged. Single case reports will be considered only if they may represent a significant advancement in the comprehension of pathophysiological mechanisms.

Associate Editor

Shuliang Jiao, PhD, Florida International University, USA

Editorial Board Members

Kamran Avanaki, PhD, University of Illinois at Chicago, USA

Zygmunt (Karol) Gryczynski, PhD, Texas Christian University, USA

Xinmai Yang, PhD, The University of Kansas, USA

Xincheng Yao, PhD, University of Illinois at Chicago, USA

Baohong Yuan, PhD, University of Texas at Arlington, USA

Weizhao Zhao, PhD, University of Miami, Florida, USA

Advisory board and editorial team

Journal information

Journal categories

Open access statement

EBM provides online free gold open access to the journal and all of its research publications.

Open Access funder and institutional mandates: EBM is fully compliant with open access mandates, by publishing its articles under the Creative Commons Attribution license  (CC-BY). Funder mandates such as those by the Wellcome Trust (UK), National Institutes of Health (USA) and the Australian Research Council (Australia) are fully compatible with publishing in EBM. Authors retain copyright of their work and can deposit their publication in any repository. The work can be freely shared and adapted provided that appropriate credit is given and any changes specified.

Copyright statement

Quality

Contact

Frontiers Editorial Office

Avenue du Tribunal Fédéral 34

CH – 1005 Lausanne

Switzerland

For queries regarding thematic issues, fee support, and any other questions, please contact development@ebm-journal.org

For all queries regarding manuscripts in review or potential conflicts of interest, please contact ebm@ebm-journal.org

EBM Editorial Offices

IT HelpDesk

For technical issues, please visit our HelpDesk, or contact our IT HelpDesk team at  support@ebm-journal.org